Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03834688
Brief Title: Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405)

First Submitted : February 6, 2019
First Submitted that Met QC Criteria : February 6, 2019
First Posted : February 8, 2019

Last Update Submitted that Met QC Criteria : June 23, 2021
Last Update Posted : June 25, 2021